Combined heterozygosity of factor V Leiden and the G20210A prothrombin gene mutation in a patient with cerebral cortical vein thrombosis

American Journal of Hematology

Volumn 64, Issue 3, 2000, Pages 226-228

  Liu, Xiao Yuan ^a   Gabig, Theodore G ^a   Bang, Nils U ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RILEY HOSPITAL FOR CHILDREN   (United States)

Author keywords

Cerebral venous thrombosis; Factor V Leiden; Prothrombin gene mutation

Indexed keywords

ACETYLSALICYLIC ACID; BLOOD CLOTTING FACTOR 5 LEIDEN; PHENYTOIN; PROTHROMBIN; WARFARIN;

ADULT; ARTICLE; BRAIN ANGIOGRAPHY; BRAIN VEIN; CASE REPORT; GENE MUTATION; HETEROZYGOSITY; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RISK FACTOR; STROKE; THROMBOSIS;

ADULT; CEREBRAL CORTEX; FACTOR V; HETEROZYGOTE; HUMANS; MALE; MUTATION; POINT MUTATION; PROTHROMBIN; VENOUS THROMBOSIS;

EID: 0034131190     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-8652(200007)64:3<226::AID-AJH17>3.0.CO;2-F     Document Type: Article

References (13)

1. Dahlbäck B. Activated protein C resistance and thrombosis: molecular mechanisms of hypercoagulable state due to FVR506Q mutation. Semin Thromb Hemost 1999;25:273-289.
2. Leroyer C, Mercier B, Oger E, Chenu E, Abgrall JF, Ferec C, Mottier D. Prevalence of 20210A allele of the prothrombin gene in venous thromboembolism patients. Thromb Haemost 1998;80:49-51.
3. Margaglione M, Brancaccio V, Guiliani N, D'Andrea G, Cappucci G, Iannaccone L, Vecchione G, Grandone E, Di Minno G. Increased risk for venous thrombosis in carriers of the prothrombin G→A20210 gene variant. Ann Intern Med 1998;129:89-93.
4. Ridker P, Hennekens C, Miletick JP. G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous-thrombosis in a large cohort of US men. Circulation 1999;99:999-1004.
5. Makris M, Preston FE, Beauchamp NJ, Cooper PC, Daly ME, Hampton KK, Bayliss P, Peake IR, Miller GJ. Co-inheritance of the 20210A allele of the prothrombin gene increases the risk of thrombosis in subjects with familial thrombophilia. Thromb Haemost 1997;78:1426-1429.
6. De Stefano V, Martinelli I, Mannucci PM, Paciaroni K, Chiusolo P, Casorelli I, Rossi E, Leone G. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation. N Engl J Med 1999;341:801-806.
7. Martinelli I, Landi G, Merati G, Cella R, Tosettto A, Mannucci PM. Factor V gene mutation is a risk factor for cerebral venous thrombosis. Thromb Haemost 1996;76:477-478.
8. Martinelli I, Sacchi E, Landi G, Taioli E, Duca F, Mannucci PM. High risk of cerebral-vein thrombosis in carriers of prothrombin-gene mutation and in users of oral contraceptives. N Engl J Med 1998;338: 1793-1797.
9. Deschiens MA, Conrad J, Horellou MH, Ameri A, Preter M, Chedru F, Samama MM, Bousser MG. Coagulations studies, factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis. Stroke 1996;27:1724-1730.
10. Press RD, Liu XY, Beamer N, Coull BM. Ischemic stroke in the elderly. Role of the common factor V mutation causing resistance to activated protein C. Stroke 1996;27:44-48.
11. Weih M, Mehraein S,. Valdueza JM, Einhaupl KM, Vetter B, Kolozik AE. Coincidence of factor V Leiden mutation and a mutation in the prothrombin gene at position 20210 in a patient with puerperal cerebral venous thrombosis. Stroke 1998;29:1739-1740.
12. Rosendaal FR. Risk factors for venous thrombosis: prevalence, risk and interaction. Semin Hematol 1997;34:171-187.
13. Margaglione M, D'Andrea G, Colaizzo D, Cappucci G, del Popolo A, Brancaccio V, Ciampa A, Grandone E, DiMinno G. Coexistence of Factor V Leiden and Factor II A 20210 mutations and recurrent venous thromboembolism. Thromb Haemost 1999;82:1583-1587.